Merck (MRK) Closes Sale of 50% Stake in J&J-Merck Consumer Pharma JV; Gets $175M
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Join SI Premium – FREE
Merck (NYSE: MRK) sells its 50 percent stake in the J&J (NYSE: JNJ)-Merck Consumer Pharmaceuticals Co. joint venture to McNEIL-PPC Inc. for $175 million.
The JV will be renamed McNeil Consumer Pharmaceuticals Co. and will continue to market products under the PEPCID(R), MYLANTA(R), and MYLICON(R) brands.
The JV will be renamed McNeil Consumer Pharmaceuticals Co. and will continue to market products under the PEPCID(R), MYLANTA(R), and MYLICON(R) brands.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- UBS Downgrades Merck (MRK) to Neutral
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
